| Brand Name: | aa&ss |
| Model Number: | DHX-CQ |
| MOQ: | 1 set |
| Price: | $10,000 to $20,000 per set |
| Payment Terms: | T/T,L/C |
| Supply Ability: | 2 sets/month |
10 t/d EO electrochemical wastewater treatment equipment, applicable to: synthetic pharmaceutical, fermentation pharmaceutical and biopharmaceutical wastewater
Quick Details
|
Pharmaceutical wastewater treatment equipment |
|
AC200~400V wide voltage input optional |
|
Equipment power 3.5-170kW optional |
|
Pollutant removal rate: 50-100% |
|
Capable of treating all pharmaceutical wastewater |
|
No chemical agents added during operation |
|
The equipment only uses electricity |
|
Skid-mounted equipment |
|
Small footprint |
|
Ready-to-use, flexible operation time based on wastewater quality |
|
Unattended, fully automatic operation, simple maintenance |
|
Customizable on demand |
Pharmaceutical wastewater is considered a severe challenge in the field of industrial wastewater treatment due to its complex composition, high pollutant concentration, and poor biodegradability. This wastewater typically contains high concentrations of refractory organic compounds such as residual antibiotics, organic solvents, and synthetic intermediates, along with characteristics like high salinity, high color, and high biotoxicity. These properties often render traditional physicochemical and biological treatment processes inefficient, costly to operate, and prone to generating large amounts of chemical sludge or failing to eliminate environmental risks entirely. Addressing this industry pain point, our company has successfully developed efficient and stable core treatment equipment based on the principles of advanced electrochemical oxidation technology, providing reliable equipment support for solving the challenge of pharmaceutical wastewater.
The core of this process lies in the CQDHX SERIES EO electrochemical oxidation equipment developed and manufactured by our company. The equipment is designed and built based on mature and reliable principles of electrochemical advanced oxidation. Through meticulously optimized electrode structures and reactor design, it ensures the efficient generation of highly oxidizing reactive species, such as hydroxyl radicals (·OH), during operation, enabling non-selective attack and thorough mineralization of refractory organic compounds. Our company's equipment translates advanced technological principles into stable-performing, user-friendly industrial products, while achieving the core advantage of clean operation: the entire oxidation process is entirely driven by electrical energy, requiring no additional chemical dosing, thereby preventing secondary pollution at the source. Simultaneously, its reaction pathway design ensures no generation of any residual solid waste, fundamentally solving the subsequent sludge disposal problems associated with traditional methods.
After conventional pre-treatment, where suspended solids are removed by physical methods and water quality is equalized to create stable and efficient operating conditions for the subsequent electrochemical equipment, the wastewater first enters EC electrochemical equipment. Here, colloids, color, and some organic matter are effectively removed. The pre-treated wastewater then finally enters the CQDHX SERIES EO electrochemical oxidation equipment for advanced purification. In this stage, our equipment, leveraging its superior electrode materials, precise flow field design, and intelligent control system, ensures the high efficiency and cost-effectiveness of the electrochemical oxidation process. It can stably and continuously degrade pollutants in pharmaceutical wastewater.
Finally, the effluent after advanced oxidation undergoes simple neutralization and can be stably discharged meeting standards.
This treatment process, centered around our self-developed EC and CQDHX SERIES EO electrochemical equipment, offers an efficient, clean, and easily manageable treatment pathway for high-difficulty pharmaceutical wastewater. Through superior equipment manufacturing and system integration, our company transforms the theoretical advantages of electrochemical oxidation technology into stable, verifiable treatment results at the user's site, assisting pharmaceutical enterprises in achieving sustainable development goals in a more environmentally friendly and economical manner.
For wastewater with special characteristics or unique treatment objectives, our company's engineers provide technical support and solutions.
Technical specifications for 10 tons/day wastewater treatment capacity
|
Equipment Model |
DHX-CQ/10 |
|
Electrode Model |
CQ-350-10-3 |
|
Number of Electrodes |
20 sets |
|
Input Voltage |
AC200-400V |
|
Power Supply Efficiency |
≥85% |
|
Frequency Range |
50-60Hz |
|
Operating Voltage |
DC3-15V |
|
Operating Current |
4000-5500A |
|
Operating Time |
0.1-24h/day |
|
Operating Temperature |
1-80℃ |
|
Influent COD |
10000-300000mg/L |
|
COD Removal Rate |
50-100% |
|
Pipe Connection Size |
DN80 |
|
Equipment Net Weight |
1200kg |
|
Equipment Dimensions |
5x3x3.5m |
Precautions:
Application Scope:
Chemical synthesis pharmaceutical wastewater, fermentation pharmaceutical wastewater, traditional Chinese medicine pharmaceutical wastewater, bioengineering pharmaceutical wastewater, preparation production wastewater, etc.
![]()
![]()
Partial Treatment Data for Pharmaceutical Wastewater
Antibiotic chemical synthesis centrifuge mother liquor, the wastewater mainly contains 50% ammonium chloride, 50% hydroxylamine hydrochloride, 10% methanol, with a salt content of 28.5%.
![]()
|
Time |
COD |
COD Removal Rate |
|
0 |
168000 |
0.00% |
|
2 |
104080 |
38.05% |
|
4 |
58800 |
65.00% |
|
6 |
17890 |
89.35% |
|
8 |
8578 |
94.89% |
|
10 |
6772 |
95.97% |
![]()
The wastewater is from chemical raw material manufacturing, primarily containing benzene DMF, with the salt content mainly being sodium sulfate.
![]()
|
Time |
COD |
COD Removal Rate |
|
0 |
12790 |
0.00% |
|
2 |
5415 |
57.66% |
|
4 |
3988 |
68.82% |
|
6 |
1053 |
91.77% |
|
8 |
150 |
98.83% |
|
10 |
0 |
100.00% |
![]()
Wastewater from: synthesis, esterification reaction, and extraction production processes. The primary pollutants include ketones, acyl chlorides, ethyl mercaptan, catalysts, and phosphoric acid.
![]()
|
Time |
COD |
COD Removal Rate |
|
0 |
25580 |
0.00% |
|
2 |
20170 |
21.15% |
|
4 |
15950 |
37.65% |
|
6 |
11440 |
55.28% |
|
8 |
3010 |
88.23% |
|
10 |
752.5 |
97.06% |
![]()
Wastewater from: nitrification using mixed acid (sulfuric acid and nitric acid); wastewater generated from water washing after separating waste acid post-nitrification; and mixed wastewater from other process streams.
![]()
|
Time |
COD |
COD Removal Rate |
|
0 |
308200 |
0.00% |
|
3 |
267280 |
13.28% |
|
5 |
103200 |
66.52% |
|
7 |
78240 |
74.61% |
|
9 |
10232 |
96.68% |
|
11 |
6140 |
98.01% |
![]()
Common Processes for Treating Pharmaceutical Wastewater with Electrochemical Equipment
Process 1
High Toxicity, Refractory Pharmaceutical Wastewater
↓
Pretreatment System (Optional)
(Enhances the efficiency of the electrochemical oxidation system)
↓
CQDHX SERIES EO Electrochemical Oxidation Treatment Equipment
(Highly efficient detoxification and COD degradation)
↓
Emission
Process 2
High Toxicity, Refractory Pharmaceutical Wastewater
↓
Pretreatment System (Optional)
(Enhances the efficiency of the electrochemical oxidation system)
↓
EC Electrochemical System
(Removes suspended solids and degrades COD)
↓
CQDHX SERIES EO Electrochemical Oxidation Treatment Equipment
(Highly efficient detoxification and COD degradation)
↓
Emission
Treatment Capacity of Electrochemical Oxidation Wastewater Treatment Equipment
|
Unit Wastewater Treatment Capacity |
Primary Pollutants |
Pollutant Removal Rate |
|
0.5-30T/h |
Toxic substances |
50-99% |
|
Organic matter |
50-100% |
|
|
Ammonia nitrogen |
30-99% |
|
|
Color |
50-95% |
|
|
Suspended Solids |
90-99% |